Synaptive Medical Showcases First Clinical Use of Near-Infrared Fluorescence Visualization on Robotic Exoscope at the American Association of Neurological Surgeons Annual Meeting
April 30 2024 - 12:57PM
Synaptive Medical Inc., a global med tech and technology company
solving surgical, imaging and data challenges, will showcase its
near-infrared fluorescence visualization setting, Modus IR, at this
year’s American Association of Neurological Surgeons (AANS)
meeting, taking place in Chicago, Illinois, from May 3 – 6.
Synaptive’s Modus IR fluorescence adds to the existing
fluorescence offering that can be utilized on its 4K 3D robotic
exoscope, Modus X, and bolsters the complete offering of
Synaptive’s exoscope for use across all neurosurgical procedures,
as well as in plastic and ENT surgery.
“Modus X can now unquestionably be applied to all complex
cerebrovascular procedures. The transition from operating under
white light to the fluorescence view is seamless and simplifies the
workflow for otherwise complex procedures,” said Dr. Richard
Williamson, MD, FAANS, Allegheny General Hospital.
Since FDA clearance in March, Modus IR fluorescence has been
used for complex cerebrovascular procedures including aneurysm
clippings, cerebral bypass, and arteriovenous malformations. In
addition, ENT and Plastic surgeons have utilized Modus IR to
perform free flap tissue transfers.
Feedback from surgeons using Modus IR fluorescence indicates
they can place the optics further away from the anatomy than would
be required with traditional optics, which results in the
streamlining of workflow while still providing improved contrast of
fluorescent tissue.
The addition of intraoperative IR fluorescence visualization, in
combination with Synaptive's MRI and tractography enabled
neuro-navigation, enhances Synaptive’s perioperative approach to
diagnosis and treatment of cerebrovascular diseases.
You can visit Synaptive Medical at AANS at booth 723 and also
see Dr. Richard Williamson speak about his first-in-the-world
utilization of exoscopic LED-powered infrared fluorescence
visualization for complex cerebrovascular procedures on Friday, May
3 at 7:20pm in the AANS NeuroHub. Synaptive will also be
participating in two medical education courses on Friday, May 3,
that focus on fundamental approaches for neurosurgery, including
minimally invasive approaches.
Find out more about Synaptive at AANS:
https://information.synaptivemedical.com/aans-2024-resources
Contact for journalistsAlastair
Harris-CartwrightE-mail:
alastair.harris-cartwright@synaptivemedical.com
About Synaptive Medical Inc.
Synaptive Medical Inc., a Toronto-based, high growth global
medical technology company, solves surgical, imaging, and data
challenges to improve the quality of human lives. Synaptive’s
integrated suite of products – bridging MRI, surgical planning,
navigation, and robotic visualization – delivers patient-centric
information with automated efficiency across all stages of clinical
interventions.
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/6dc94b3c-def0-4e3e-b4d2-db6d273f9e33
https://www.globenewswire.com/NewsRoom/AttachmentNg/aa1407d0-48f0-43ce-8ff9-fb4fed761992